author-photo

Kimio Yonesaka

Kindai University

86

Papers

2346

Citations

Citation Trend

Filter By

Papers (53) Sort By

Journal Conference Others

CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M-positive lung cancer after osimertinib.

2021 International Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
MO4-1 EGFR inhibitor upregulates HER3 expression and enhances the efficacy of anti-HER3 antibody drug conjugate U3-1402

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
HER2-/HER3-Targeting Antibody—Drug Conjugates for Treating Lung and Colorectal Cancers Resistant to EGFR Inhibitors

2021 Cancers
- Kimio Yonesaka
Show All
- Source
- Cite
- Save
Citations (3)
Vascular endothelial growth factor (VEGF)-D and clinical outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with second-line FOLFIRI plus bevacizumab (Bev): A biomarker study of the WJOG 6210G trial.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of coexisting gene mutations in EGFR-mutated non-small cell lung cancer before treatment on EGFR T790M mutation status after EGFR-TKIs.

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Severe Immune-Related Hepatitis Treated With Plasma Exchange

2020 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors

2020 Oncologist
Show All
- Source
- Cite
- Save
Citations (9)
Abstract 1668: A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing

2019 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (9)
Aberrant HER3 ligand heregulin-expressing head and neck squamous cell carcinoma is resistant to anti-EGFR antibody cetuximab, but not second-generation EGFR-TKI

2019
Show All
- Source
- Cite
- Save
Citations (5)